100 - Primary Outcome Analysis for Shortening Adjuvant Photon Irradiation to Reduce Edema (SAPHIRE): A Randomized, Phase III Trial of Hypo- vs. Conventionally Fractionated Regional Nodal Irradiation (RNI)
101 - Long Term Rates of Lymphedema in Hypofractionated Nodal Regional Irradiation for Women with Breast Cancer: A Phase 2 Clinical Trial - "HeNRIetta"
Location: Room 202
Presenter: Alfredo Urdaneta, MD – Virginia Commonwealth University Health System
8:20 AM - 8:30 AM ET
102 - NOVEMBER, A Phase II Trial of a 9 Day Course of Whole Breast Radiotherapy for Early Stage Breast Cancer
103 - Early Safety of Ultra-Hypofractionated Whole Breast Irradiation and Sequential Tumor Bed Boost for Early Breast Cancer (SHIFT): A Multicenter, Phase 2 Trial
Location: Room 202
Presenter: Siyue Zheng, MD – Ruijin Hospital, Shanghai Jiaotong University School of Medicine
8:40 AM - 8:50 AM ET
104 - Conventional vs. Hypofractionated Proton Postmastectomy Radiotherapy: Patient Reported Outcomes from a Randomized Phase 2 Trial
107 - Moderated Hypofractionated Online Adaptive Radiotherapy in Locally Advanced Cervical Cancer: A Prospective 1 Clinical Trial
Location: Room 204
Presenter: Zheng Zeng, MD – Peking Union Medical College Hospital
8:30 AM - 8:40 AM ET
108 - Acceleration of Overall Treatment Time by Mono-Application Multifractionated Brachytherapy over 48 Hours vs. Sequential Weekly Application Brachytherapy in Carcinoma Cervix - Multi-Institutional, Subc
109 - Image Guided Brachytherapy Quality Assurance on NRG GY017, an NRG Oncology Clinical Trial Investigating the Sequencing of Immunotherapy and Chemoradiation for Locally Advanced Cervical Cancer
Location: Room 204
Presenter: Hayeon Kim, PhD – Magee Womens Hospital of University of Pittsburgh Medical Center and Hillman Cancer Center
8:50 AM - 9:00 AM ET
Discussant
Location: Room 204
Discussant: Scott Glaser, MD – City of Hope National Medical Center
8:00 AM - 8:10 AM ET
110 - Clinical Outcomes for Standard of Care Machine Learning Prostate Radiotherapy Treatment Planning
111 - DeepTuning: A Novel Deep Learning Approach for Interactive Plan Tuning and Trade-Off Exploration
Location: Room 147
Presenter: Lin Ma, PhD – Mayo Clinic College of Medicine and Science Rochester
8:20 AM - 8:30 AM ET
112 - Initial Clinical Experience of Cherenkov Imaging in Sub-Total Total Skin Electron Therapy Identifies Opportunities to Improve Daily Set-Up QA
Location: Room 147
Presenter: Brook Byrd, PhD, MS, BS – Penn Medicine Radiation Oncology Abramson Cancer Center
8:30 AM - 8:40 AM ET
113 - Individual Radiotherapy Plan Based on Multi-Omics Model Study for Cervical Cancer Patients with Ovarian Preservation
Location: Room 147
Presenter: Guang Li, PhD – Chongqing University Cancer Hospital
8:40 AM - 8:50 AM ET
114 - Results of a Dose Reconstruction Effort for a Large-Scale Retrospective Study on Late Health Effects Following Radiotherapy within the National Wilms Tumor Study
1000 - Impact of Prior Local Therapy (LT) on Treatment Response and Survival of Men with Metastatic Castrate Resistant Prostate Cancer (mCRPC): A Pooled Analysis of COU-AA-302 and ACIS Trials
Location: Room 207 B
Presenter: Omar Azem, MD – Rush University Medical Center
8:10 AM - 8:15 AM ET
1001 - Post-Prostatectomy Linac-Based Ultrahypofractionated Radiotherapy for Patients with Localized Prostate Cancer: Toxicity and Quality-of Life Results from a Prospective Trial
1002 - Radiotherapy of the Primary Tumor and All Metastatic Lesions in Oligometastatic Prostate Cancer: 5-Year Results of Prolong Study
Location: Room 207 B
Presenter: Xin Qi, MD, MS – Peking University First Hospital
8:20 AM - 8:25 AM ET
1003 - Initial Results of a Phase 2 Trial of Stereotactic Body Radiation Therapy, Hormone/Androgen Deprivation Therapy and Radium 223 Dichloride for Oligometastatic Castrate Sensitive Prostate Cancer (SHARP)
1004 - Stereotactic Body Radiation Therapy (SBRT) Combined with Pelvic Radiotherapy and GTV Boost Based on Multiparameter Magnetic Resonance Image for High-Risk Prostate Cancer: A Phase II Study
1005 - A Prospective Pilot Study Investigating 18F rhPSMA-7.3 PET/MRI to Detect Recurrent Disease and Guide Radiotherapy Planning in Patients with Biochemically Recurrent Prostate Cancer Post-Pros
2 - A Prospective, Phase II Study of 177Lu-Dotatate in Patients with Surgery- and Radiation-Refractory Meningioma: Results of the WHO Grade II/III Cohort
3 - A Phase 3 Study of Pembrolizumab (Pembro) + Concurrent Chemoradiotherapy (CCRT) for High-Risk Locally Advanced Cervical Cancer (LACC): Safety Findings
4 - Hypofractionated Whole-Breast Irradiation with Simultaneous Integrated Boost for Breast Cancer: Primary Analysis of the HYPOSIB-Trial (ARO 2013-05)
Location: Ballroom A/B/C
Presenter: David Krug, MD – University Hospital Hamburg-Eppendorf
LBA06 - Short-Term Androgen Deprivation Therapy and High-Dose Radiotherapy in Intermediate- and High-Risk Localized Prostate Cancer: Results from the GETUG 14 Randomized Phase III Trial
LBA07 - A Multicenter Phase III Randomized Clinical Trial Comparing the Efficacy of an Adjuvant SOX Chemotherapy Regimen with SOX Combined with a Simultaneous Radiotherapy Regimen after D2 Radical Resection f
Location: Ballroom A/B/C
Presenter: Ou-ying Yan, MD – Cancer Center, West China Hospital, Sichuan University
2:45 PM - 2:55 PM ET
130 - MORF4L1-Mediated DNA Damage Repair Modulates cGAS-STING Activation and Radiosensitivity in Hepatocellular Carcinoma
Location: Room 152
Presenter: Siwei Wang, PhD – Department of Radiation Oncology, Cancer Center, Zhongshan Hospital, Fudan University
2:55 PM - 3:05 PM ET
131 - Unraveling the Mechanism behind Prophylactic Radiotherapy to Prevent Traumatic Heterotopic Ossification
1007 - Efficacy of Quantitative Targeted Exercise Combined with Full-Scale Refined Nutrition Management for Improving Nutrition in Patients with Head and Neck Cancer Receiving Radiotherapy - A Randomized Con
Location: Room 158
Presenter: Juanli Shi – Xijing Hospital Air Force Medical University
3:00 PM - 3:05 PM ET
1008 - The HEART Team Protocol: A Strategic Approach to High-Risk Patient Management in Adult Oncology to Reduce Emergency Room Visits and Hospital Admissions
1009 - Efficacy and Safety of a Dexamethasone-Free Antiemetic Regimen for Nausea and Emesis Prevention during Concurrent Chemoradiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma (LA-HNSCC
1010 - Development of a Program Utilizing the Simple Measure of Gobbledygook (SMOG) Algorithm for Comprehending Patient-Generated Educational Content in the Field of Radiation Oncology
138 - The Prognostic Value of Pretreatment Carbohydrate Antigen 125 Level in Cervical Cancer Patients Treated with Definitive Radiotherapy or Concurrent Chemoradiotherapy
Location: Room 207 B
Presenter: Dingchao Liu, MD – Peking Union Medical College Hospital
3:15 PM - 3:25 PM ET
139 - Longitudinal Dynamic MRI Radiomic Models for Early Prediction of Prognosis in Locally Advanced Cervical Cancer Treated with Concurrent Chemoradiotherapy
141 - Effect of Cisplatin Cycles on Prognosis for Locally Advanced Cervical Cancer Patients Treated with Concurrent Chemoradiotherapy: A Long-Term Follow-Up, Large Cohort Study
Location: Room 207 B
Presenter: Zheng Zeng, MD – Peking Union Medical College Hospital
123 - Efficacy of Kangfuxin Liquid Retention Enema in Preventing and Treating Radiation-Induced Proctitis in Cervical Cancer Patients: A Randomized, Open-Label, Phase III Study
124 - Evaluating Toxicity and Interaction Outcomes of Systemic Therapy and Stereotactic Ablative Radiotherapy for Oligometastatic Disease: A Secondary Analysis of the Phase II SABR-5 Trial
125 - Impact of Clinical Target Volume Utilization on Outcomes in Patients with Non-Spine Bone Oligometastases Treated with Stereotactic Ablative Radiation Therapy
126 - Real-world implementation of simulation-free radiotherapy (SFRT-1000): A propensity score-matched analysis of 1000 consecutive palliative courses delivered in routine care
Location: Room 151
Presenter: Thilo Schuler, MD, MHInf – Northern Sydney Cancer Centre - Royal North Shore Hospital
3:25 PM - 3:35 PM ET
127 - Applying Deep Learning Based Facial Age Phenotyping to Improve Life Expectancy Prediction in Metastatic Cancer Patients Receiving Palliative Radiotherapy
Location: Room 151
Presenter: Grace Lee, MD – Harvard Radiation Oncology Program
3:35 PM - 3:45 PM ET
128 - Relationship between Cannabis Use and Opioid Use in Patients with Cancer Metastatic to Bone in a Large Multicenter Cohort from a State with Legalized Adult Non-Medical Cannabis
117 - A Prospective Interventional Clinical Trial (MC1732): Characterization of Thoracic Chemoradiotherapy-Related Cardiac Changes Using an Implantable Cardiac Monitor (ICM)
118 - Effectiveness of Nurse-Led Multimodal Rehabilitation for Patients Undergoing Postoperative Radiotherapy of Esophageal Cancer: A Randomized Controlled Trial
120 - Comparing Radiation and Systemic Therapy Patients Longitudinal Satisfaction of a Cloud-Based Bidirectional App Used for Real-Time Communication of Patient-Reported Cancer Treatment Symptoms
150 - Evaluating Neurocognitive Recovery Following Stereotactic Radiosurgery and Whole Brain Radiation Therapy: Insights from a Pooled Analysis of Three Phase III Trials
151 - Neurocognition and Quality of Life for Hypofractionated Stereotactic Radiotherapy (HFSRT) of the Resection Cavity vs. Whole-Brain Radiotherapy (WBRT) Following Brain Metastasis Resection - Results of
Location: Room 147
Presenter: Rami El Shafie, MD – University Medical Center Gottingen (UMG)
5:25 PM - 5:35 PM ET
152 - A Longitudinal Study to Correlate Neurocognitive Changes of IDH-Mutant and IDH-Wildtype Glioma Patients after Chemoradiotherapy with Changes on Resting-State MRI
Location: Room 147
Presenter: Zhihua Liu, PhD – Washington University School of Medicine in St Louis
5:35 PM - 5:45 PM ET
153 - Assessing Atrophy and Neurocognitive Decline in Hippocampal Subfields after Fractionated Brain Radiation Therapy
155 - Novel Statistical-AI Method to Automate Discovery of Predictive Factors and Thresholds for 3 Year Survival, Dysphagia and Xerostomia for Patients with Head and Neck Cancers
158 - Longitudinal CT Feature-Based Model for Predicting Local Recurrence Free Survival in Esophageal Cancer Patients Treated with Definitive Chemoradiotherapy: A Multicenter Study
159 - Explainable MRI-Based Deep Learning Model for Predicting EGFR Mutation in NSCLC Brain Metastases: Advancing Clinical Prognosis and Oncological Treatment Decisions
142 - A Phase II Trial of Camrelizumab in Combination with Concurrent Chemoradiotherapy as First-Line Treatment for Betel Nut-Related Locally Advanced Oral Squamous Cell Carcinoma
143 - Contralateral Neck Recurrence Rates in Head and Neck Carcinomas after Primary Surgery, Bilateral Neck Dissection, a Pathologically Negative Contralateral Neck, and Adjuvant Ipsilateral Neck Radiation
145 - Acupuncture for (Chemo)Radiotherapy - Related Dysphagia in Patients with Head and Neck Squamous Cell Carcinoma (HNSCC): A Randomized Phase 2 Study
147 - Long Term Effects of Cognitive Behavioral Therapy on Late Toxicities, Depressive and Anxiety Symptoms in Patients with Locoregional Advanced Nasopharyngeal Carcinoma Undergoing Chemoradiotherapy: A Ra